Institutional investors purchased a net $1.4 million shares of XNPT during the quarter ended March 2015 and now own 90.40% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.1 Million shares of Xenoport Inc
SSGA FUNDS MANAGEMENT, INC. Bought 1.4 Million shares of Xenoport Inc
INVESCO ADVISERS, INC. Bought 513.5 Thousand shares of Xenoport Inc